U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07879937) titled 'Artificial Intelligence Integration in Breast Cancer Screening: The ANIHTA Study' on Oct. 05.
Brief Summary: The goal of this observational study is to evaluate how artificial intelligence (AI) can be integrated into an organized breast cancer screening program for women aged 50-74 years undergoing mammography screening.
The main questions it aims to answer are:
* Can an AI-based workflow that identifies selected mammograms for review by a third radiologist improve or maintain the cancer detection rate compared with the current AI-supported double-reading workflow?
* How would this AI-based workflow affect recall rates, biopsy re...